Discontinued — last reported Q4 '25

Business Segments · Total Assets

Contract-Manufactured Products — Total Assets

West Pharmaceutical Services Contract-Manufactured Products — Total Assets increased by 4.7% to $718.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $612.20M to $718.10M.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2025
Rolls up toTotal Assets

How to read this metric

Growth in assets relative to revenue may indicate capital-intensive expansion, while stable assets with growing revenue suggest improved asset utilization.

Detailed definition

The total value of resources controlled by the contract-manufacturing segment, including property, plant, equipment, inv...

Peer comparison

Standard 'Segment Assets' reported in the notes to financial statements for diversified companies.

Metric ID: wst_segment_contract_manufactured_products_assets

Historical Data

8 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$443.70M$480.30M$527.50M$612.20M$627.70M$667.90M$685.90M$718.10M
QoQ Change+8.2%+9.8%+16.1%+2.5%+6.4%+2.7%+4.7%
YoY Change+8.2%+9.8%+16.1%+17.3%
Range$443.70M$718.10M
CAGR+31.7%
Avg YoY Growth+12.9%
Median YoY Growth+12.9%
Current Streak7+ quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's contract-manufactured products — total assets?
West Pharmaceutical Services (WST) reported contract-manufactured products — total assets of $718.10M in Q4 2025.
How has West Pharmaceutical Services's contract-manufactured products — total assets changed year-over-year?
West Pharmaceutical Services's contract-manufactured products — total assets increased by 17.3% year-over-year, from $612.20M to $718.10M.
What does contract-manufactured products — total assets mean?
The total value of assets owned and used by the contract-manufacturing segment.